Medtronic reveals 12-month study data for DTM SCS therapy

Medtronic reveals 12-month study data for DTM SCS therapy

Source: 
Clinical Trials Arena
snippet: 

Medtronic has announced study results that show its differential target multiplexed (DTM) spinal cord stimulation (SCS) therapy can significantly reduce pain in patients with chronic back pain, compared to conventional SCS therapy. .